Literature DB >> 1385430

Characterization of a 97-kDa phosphotyrosylprotein regulated by multiple cytokines.

D Linnekin1, G Evans, D Michiel, W L Farrar.   

Abstract

We have examined the signal transduction pathways of a number of cytokines that interact with receptors that are members of the hematopoietin receptor superfamily. A 97-kDa protein was phosphorylated on tyrosine in response to stimulation of appropriate target cells with interleukin (IL)-2, IL-3, granulocyte-macrophage colony-stimulating factor (CSF), granulocyte-CSF, or erythropoietin. These data suggest that a 97-kDa phosphotyrosylprotein represents a point of convergence for signal transduction by a number of growth factor receptors that do not have homology with any known protein tyrosine kinase. To address the possibility that p97 may represent a tyrosine kinase involved in multiple signal transduction pathways, we tested the capacity of this protein to bind a tyrosine kinase substrate or ATP. Indeed, a 97-kDa phosphotyrosylprotein purified from IL-2-stimulated lymphoid cells as well as granulocyte-macrophage-CSF-stimulated myeloid cells bound to a polymer of glutamic acid and tyrosine which is a tyrosine kinase substrate. Further, a 97-kDa phosphotyrosylprotein present in both lineages also bound 8-azido-ATP. These data indicate that a 97-kDa phosphotyrosylprotein with properties consistent with those of a protein tyrosine kinase is involved in the signal transduction pathways of certain members of the newly identified hematopoietin receptor superfamily and may represent an early point of convergence in the stimulus-response coupling of multiple cytokine receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.

Authors:  J Cohen; H Altaratz; Y Zick; U Klingmüller; D Neumann
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

2.  cAMP suppresses p21ras and Raf-1 responses but not the Erk-1 response to granulocyte-colony-stimulating factor: possible Raf-1-independent activation of Erk-1.

Authors:  X F Csar; A C Ward; B W Hoffmann; G G Guy; J A Hamilton
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases.

Authors:  S J Corey; A L Burkhardt; J B Bolen; R L Geahlen; L S Tkatch; D J Tweardy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Murine T-lymphocyte proliferation induced by interleukin 2 correlates with a transient increase in p56lck kinase activity and the tyrosine phosphorylation of a 97-kDa protein.

Authors:  Y H Kim; M J Buchholz; A A Nordin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.

Authors:  D S Finbloom; E F Petricoin; R H Hackett; M David; G M Feldman; K Igarashi; E Fibach; M J Weber; M O Thorner; C M Silva
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

6.  Erythropoietin and interleukin-2 activate distinct JAK kinase family members.

Authors:  D L Barber; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

7.  Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.

Authors:  A L Mui; H Wakao; A M O'Farrell; N Harada; A Miyajima
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

8.  Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells.

Authors:  I Dusanter-Fourt; O Muller; A Ziemiecki; P Mayeux; B Drucker; J Djiane; A Wilks; A G Harpur; S Fischer; S Gisselbrecht
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.